Glenmark Pharmaceuticals has informed that it attached media release dated on 16th June 2022, titled ‘Glenmark becomes the First Pharmaceutical Company to launch Indacaterol + Mometasone Fixed-Dose Combination Drug for Asthma in India’.
The above information is a part of company’s filings submitted to BSE.